Exchange: NASDAQ·Updated 10:13 AM EDT

ABIO ARCA biopharma Inc

$85.93
$4.00
(4.44%)
Today
Mkt Cap$5.95B
Vol98,974.00

About ABIO

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
48

Neutral Sentiment

How do you feel about ABIO?

Advertisement|Remove ads.